Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa

Acute rheumatic fever and its chronic sequelae, rheumatic cardiac disease, and neuropsychiatric movement disorders, remain major public health problems in South Africa. Early identification and treatment of streptococcal pharyngitis in susceptible individuals would prevent rheumatic cardiac disease....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiology in the young 2011-06, Vol.21 (3), p.328-333
Hauptverfasser: Walker, Kathleen G., Cooper, Margaret, McCabe, Karin, Hughes, Jane, Mathiassen, Wendy, Lawrenson, John, Wilmshurst, Jo M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 333
container_issue 3
container_start_page 328
container_title Cardiology in the young
container_volume 21
creator Walker, Kathleen G.
Cooper, Margaret
McCabe, Karin
Hughes, Jane
Mathiassen, Wendy
Lawrenson, John
Wilmshurst, Jo M.
description Acute rheumatic fever and its chronic sequelae, rheumatic cardiac disease, and neuropsychiatric movement disorders, remain major public health problems in South Africa. Early identification and treatment of streptococcal pharyngitis in susceptible individuals would prevent rheumatic cardiac disease. The B-cell antigen D8/17 is a marker of susceptibility to rheumatic fever in some populations. We assessed the significance of the D8/17 marker in a group of South Africans. Blood was collected from 107 individuals; 40 patients had previous confirmed rheumatic fever, 20 were first-degree relatives, and 47 were controls. The expression of D8/17 in each sample was analysed by flow cytometry. The mean proportion of B-cells that were D8/17 positive was 0.5% in the index cases, 0.47% in their relatives, and 0.27% in the controls. There was a significant difference between the index cases and the controls, p = 0.03, but the mean percentage positive in each group was very low. Patients with a history of rheumatic fever had statistically increased expression of the D8/17 marker. However, the actual percentages in this observational study were markedly lower than in other populations, ranging from 0.14%-1.53% compared to 11.6%-39.3%. The D8/17 marker would be an impractical screening tool in the South African population.
doi_str_mv 10.1017/S1047951111000035
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_885563925</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S1047951111000035</cupid><sourcerecordid>2343837501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-ef9318602d420cfb4c21c048031f7c22a53acddffc607f6435d27a6114095d913</originalsourceid><addsrcrecordid>eNp1kU1P3DAQhq0KVGDLD-ilGnHpKeCJ4zjhRvmWQBwo58hxbNawibf-QOLf44VtkaiYy4w17zwz1kvId6T7SFEc3CKtRMsxB83B-BeyjVUtivwWG7nO7WLV3yI7ITxQiowh_Uq2SmRZLZpt8nQt_aP2AZyBkILSy2h7u7DxGaIDqVLU4Oc6jTJaBUY_aX8Ica7hV6H0YgFyivZeT3DSHKAAG2ByEbzrU4ggA0gYX_lgJ7h1Kc7hyHir5DeyaeQi6N11npG7s9PfxxfF1c355fHRVaGYwFho0zJsaloOVUmV6StVoqJVQxkaocpScibVMBijaipMXTE-lELWiBVt-dAim5Gfb9yld3-SDrEbbVgdLiftUuiahvOatSXPyr0PygeX_JSP65qatxVvM35G8E2kvAvBa9Mtvc0_fO6QditLuv8syTM_1uDUj3r4N_HXgyxga6gce2-He_2--nPsC9UVk58</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>865945964</pqid></control><display><type>article</type><title>Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa</title><source>MEDLINE</source><source>Cambridge Journals</source><creator>Walker, Kathleen G. ; Cooper, Margaret ; McCabe, Karin ; Hughes, Jane ; Mathiassen, Wendy ; Lawrenson, John ; Wilmshurst, Jo M.</creator><creatorcontrib>Walker, Kathleen G. ; Cooper, Margaret ; McCabe, Karin ; Hughes, Jane ; Mathiassen, Wendy ; Lawrenson, John ; Wilmshurst, Jo M.</creatorcontrib><description>Acute rheumatic fever and its chronic sequelae, rheumatic cardiac disease, and neuropsychiatric movement disorders, remain major public health problems in South Africa. Early identification and treatment of streptococcal pharyngitis in susceptible individuals would prevent rheumatic cardiac disease. The B-cell antigen D8/17 is a marker of susceptibility to rheumatic fever in some populations. We assessed the significance of the D8/17 marker in a group of South Africans. Blood was collected from 107 individuals; 40 patients had previous confirmed rheumatic fever, 20 were first-degree relatives, and 47 were controls. The expression of D8/17 in each sample was analysed by flow cytometry. The mean proportion of B-cells that were D8/17 positive was 0.5% in the index cases, 0.47% in their relatives, and 0.27% in the controls. There was a significant difference between the index cases and the controls, p = 0.03, but the mean percentage positive in each group was very low. Patients with a history of rheumatic fever had statistically increased expression of the D8/17 marker. However, the actual percentages in this observational study were markedly lower than in other populations, ranging from 0.14%-1.53% compared to 11.6%-39.3%. The D8/17 marker would be an impractical screening tool in the South African population.</description><identifier>ISSN: 1047-9511</identifier><identifier>EISSN: 1467-1107</identifier><identifier>DOI: 10.1017/S1047951111000035</identifier><identifier>PMID: 21303578</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Antibodies, Monoclonal ; Biomarkers - blood ; Case-Control Studies ; Colleges &amp; universities ; Family medical history ; Female ; Fever ; Flow Cytometry ; Humans ; Isoantigens - blood ; Male ; Rheumatic fever ; Rheumatic Fever - blood ; South Africa</subject><ispartof>Cardiology in the young, 2011-06, Vol.21 (3), p.328-333</ispartof><rights>Copyright © Cambridge University Press 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-ef9318602d420cfb4c21c048031f7c22a53acddffc607f6435d27a6114095d913</citedby><cites>FETCH-LOGICAL-c371t-ef9318602d420cfb4c21c048031f7c22a53acddffc607f6435d27a6114095d913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S1047951111000035/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,776,780,27901,27902,55603</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21303578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walker, Kathleen G.</creatorcontrib><creatorcontrib>Cooper, Margaret</creatorcontrib><creatorcontrib>McCabe, Karin</creatorcontrib><creatorcontrib>Hughes, Jane</creatorcontrib><creatorcontrib>Mathiassen, Wendy</creatorcontrib><creatorcontrib>Lawrenson, John</creatorcontrib><creatorcontrib>Wilmshurst, Jo M.</creatorcontrib><title>Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa</title><title>Cardiology in the young</title><addtitle>Cardiol Young</addtitle><description>Acute rheumatic fever and its chronic sequelae, rheumatic cardiac disease, and neuropsychiatric movement disorders, remain major public health problems in South Africa. Early identification and treatment of streptococcal pharyngitis in susceptible individuals would prevent rheumatic cardiac disease. The B-cell antigen D8/17 is a marker of susceptibility to rheumatic fever in some populations. We assessed the significance of the D8/17 marker in a group of South Africans. Blood was collected from 107 individuals; 40 patients had previous confirmed rheumatic fever, 20 were first-degree relatives, and 47 were controls. The expression of D8/17 in each sample was analysed by flow cytometry. The mean proportion of B-cells that were D8/17 positive was 0.5% in the index cases, 0.47% in their relatives, and 0.27% in the controls. There was a significant difference between the index cases and the controls, p = 0.03, but the mean percentage positive in each group was very low. Patients with a history of rheumatic fever had statistically increased expression of the D8/17 marker. However, the actual percentages in this observational study were markedly lower than in other populations, ranging from 0.14%-1.53% compared to 11.6%-39.3%. The D8/17 marker would be an impractical screening tool in the South African population.</description><subject>Antibodies, Monoclonal</subject><subject>Biomarkers - blood</subject><subject>Case-Control Studies</subject><subject>Colleges &amp; universities</subject><subject>Family medical history</subject><subject>Female</subject><subject>Fever</subject><subject>Flow Cytometry</subject><subject>Humans</subject><subject>Isoantigens - blood</subject><subject>Male</subject><subject>Rheumatic fever</subject><subject>Rheumatic Fever - blood</subject><subject>South Africa</subject><issn>1047-9511</issn><issn>1467-1107</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU1P3DAQhq0KVGDLD-ilGnHpKeCJ4zjhRvmWQBwo58hxbNawibf-QOLf44VtkaiYy4w17zwz1kvId6T7SFEc3CKtRMsxB83B-BeyjVUtivwWG7nO7WLV3yI7ITxQiowh_Uq2SmRZLZpt8nQt_aP2AZyBkILSy2h7u7DxGaIDqVLU4Oc6jTJaBUY_aX8Ica7hV6H0YgFyivZeT3DSHKAAG2ByEbzrU4ggA0gYX_lgJ7h1Kc7hyHir5DeyaeQi6N11npG7s9PfxxfF1c355fHRVaGYwFho0zJsaloOVUmV6StVoqJVQxkaocpScibVMBijaipMXTE-lELWiBVt-dAim5Gfb9yld3-SDrEbbVgdLiftUuiahvOatSXPyr0PygeX_JSP65qatxVvM35G8E2kvAvBa9Mtvc0_fO6QditLuv8syTM_1uDUj3r4N_HXgyxga6gce2-He_2--nPsC9UVk58</recordid><startdate>201106</startdate><enddate>201106</enddate><creator>Walker, Kathleen G.</creator><creator>Cooper, Margaret</creator><creator>McCabe, Karin</creator><creator>Hughes, Jane</creator><creator>Mathiassen, Wendy</creator><creator>Lawrenson, John</creator><creator>Wilmshurst, Jo M.</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201106</creationdate><title>Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa</title><author>Walker, Kathleen G. ; Cooper, Margaret ; McCabe, Karin ; Hughes, Jane ; Mathiassen, Wendy ; Lawrenson, John ; Wilmshurst, Jo M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-ef9318602d420cfb4c21c048031f7c22a53acddffc607f6435d27a6114095d913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antibodies, Monoclonal</topic><topic>Biomarkers - blood</topic><topic>Case-Control Studies</topic><topic>Colleges &amp; universities</topic><topic>Family medical history</topic><topic>Female</topic><topic>Fever</topic><topic>Flow Cytometry</topic><topic>Humans</topic><topic>Isoantigens - blood</topic><topic>Male</topic><topic>Rheumatic fever</topic><topic>Rheumatic Fever - blood</topic><topic>South Africa</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walker, Kathleen G.</creatorcontrib><creatorcontrib>Cooper, Margaret</creatorcontrib><creatorcontrib>McCabe, Karin</creatorcontrib><creatorcontrib>Hughes, Jane</creatorcontrib><creatorcontrib>Mathiassen, Wendy</creatorcontrib><creatorcontrib>Lawrenson, John</creatorcontrib><creatorcontrib>Wilmshurst, Jo M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiology in the young</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walker, Kathleen G.</au><au>Cooper, Margaret</au><au>McCabe, Karin</au><au>Hughes, Jane</au><au>Mathiassen, Wendy</au><au>Lawrenson, John</au><au>Wilmshurst, Jo M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa</atitle><jtitle>Cardiology in the young</jtitle><addtitle>Cardiol Young</addtitle><date>2011-06</date><risdate>2011</risdate><volume>21</volume><issue>3</issue><spage>328</spage><epage>333</epage><pages>328-333</pages><issn>1047-9511</issn><eissn>1467-1107</eissn><abstract>Acute rheumatic fever and its chronic sequelae, rheumatic cardiac disease, and neuropsychiatric movement disorders, remain major public health problems in South Africa. Early identification and treatment of streptococcal pharyngitis in susceptible individuals would prevent rheumatic cardiac disease. The B-cell antigen D8/17 is a marker of susceptibility to rheumatic fever in some populations. We assessed the significance of the D8/17 marker in a group of South Africans. Blood was collected from 107 individuals; 40 patients had previous confirmed rheumatic fever, 20 were first-degree relatives, and 47 were controls. The expression of D8/17 in each sample was analysed by flow cytometry. The mean proportion of B-cells that were D8/17 positive was 0.5% in the index cases, 0.47% in their relatives, and 0.27% in the controls. There was a significant difference between the index cases and the controls, p = 0.03, but the mean percentage positive in each group was very low. Patients with a history of rheumatic fever had statistically increased expression of the D8/17 marker. However, the actual percentages in this observational study were markedly lower than in other populations, ranging from 0.14%-1.53% compared to 11.6%-39.3%. The D8/17 marker would be an impractical screening tool in the South African population.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>21303578</pmid><doi>10.1017/S1047951111000035</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1047-9511
ispartof Cardiology in the young, 2011-06, Vol.21 (3), p.328-333
issn 1047-9511
1467-1107
language eng
recordid cdi_proquest_miscellaneous_885563925
source MEDLINE; Cambridge Journals
subjects Antibodies, Monoclonal
Biomarkers - blood
Case-Control Studies
Colleges & universities
Family medical history
Female
Fever
Flow Cytometry
Humans
Isoantigens - blood
Male
Rheumatic fever
Rheumatic Fever - blood
South Africa
title Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A21%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Markers%20of%20susceptibility%20to%20acute%20rheumatic%20fever:%20the%20B-cell%20antigen%20D8/17%20is%20not%20robust%20as%20a%20marker%20in%20South%20Africa&rft.jtitle=Cardiology%20in%20the%20young&rft.au=Walker,%20Kathleen%20G.&rft.date=2011-06&rft.volume=21&rft.issue=3&rft.spage=328&rft.epage=333&rft.pages=328-333&rft.issn=1047-9511&rft.eissn=1467-1107&rft_id=info:doi/10.1017/S1047951111000035&rft_dat=%3Cproquest_cross%3E2343837501%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=865945964&rft_id=info:pmid/21303578&rft_cupid=10_1017_S1047951111000035&rfr_iscdi=true